United Healthcare (UNH): Early-Stage Earnings Recovery Sets the Stage for Mid-Teens Compound Growth Soumya Eswaran Mon, October 12, 2026 at 11:22 AM EDT 3 min read ^GSPC -0.06% UNH -0.96% SPGI +1.36% Explore stocks on Coinbase Trading disclosure Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Patient Capital Management, based in Baltimore, released its third-quarter 2026 investor letter for the "Patient Opportunity Equity Strategy". The letter can be downloaded here. The Opportunity Equity Strategy outperformed the S&P 500 in the latest quarter, gaining 4.32% compared to 2.30%, and is up 14.93% year-to-date versus the index's 12.75%. The market shows resilience, despite rate increases presenting risks and opportunities. The current market is seen as part of a long bull run, especially since March 2009, with the S&P compounding at 16.9% per year. The AI revolution adds complexity, and investor skepticism persists amidst rising valuations, yet strong corporate earnings suggest potential. The focus remains on understanding price expectations and evaluating risks, particularly around AI durability and supply-demand for computing capacity. The portfolio is concentrated in top 10 holdings, suggesting a disciplined approach towards valuation and risk management amidst market volatility. Also, check the strategy's top five holdings to see its best picks in 2026.
In its Q3 2026 investor letter, Patient Opportunity Equity Strategy highlighted UnitedHealth Group Incorporated (NYSE:UNH). UnitedHealth Group Incorporated, a diversified healthcare company, contributed to the Fund's performance during the quarter. On October 09, 2026, UnitedHealth Group Incorporated (NYSE:UNH) closed at $379.30 per share. Over the past month UnitedHealth Group Incorporated (NYSE:UNH) was down 1.11%, and its shares gained 5.75% over the past 52 weeks. UnitedHealth Group Incorporated (NYSE:UNH) has a market capitalization of $340.46 billion and its stock has traded within a 52-week range of $255.97 to $461.62.
Patient Opportunity Equity Strategy stated the following regarding UnitedHealth Group Incorporated (NYSE:UNH) in its Q3 2026 investor letter:
"Royalty Pharma (RPRX $56.21) and UnitedHealth Group Incorporated (NYSE:UNH) ($370.95) are significant contributors for the year, but we continue to like the risk-reward in each. United Healthcare is early in its earnings recovery with an excellent management team. For the next few years, earnings should grow in the mid-teens in most environments. Both companies add ballast to the portfolio."
UnitedHealth Group Incorporated (NYSE:UNH) is in 14th position on our list of 40 Most Popular Stocks Among Hedge Funds. According to our database, 143 hedge fund portfolios held UnitedHealth Group Incorporated (NYSE:UNH) at the end of the second quarter, compared to 130 in the previous quarter. While we acknowledge the potential of UnitedHealth Group Incorporated (NYSE:UNH) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
In earlier coverage of UnitedHealth Group Incorporated (NYSE:UNH), we noted that its forward P/E has fallen sharply, raising the question of whether the market has already priced in most of its recent troubles. In addition, please check out our hedge fund investor letters Q3 2026 page for more investor letters from hedge funds and other leading investors.
This article is originally published at Insider Monkey.
